Palmar squamous cell carcinoma successfully treated by intra-arterial infusion chemotherapy - 14/11/12
Doi : 10.1016/j.jaad.2012.03.035
Yen Ting Sheen, MD a, Chung-Sheng Lai, MD a, Yi-Shuan Sheen, MD f, Sheau-Fang Yang, MD c, e, Maw-Chang Sheen, MD b, d, ⁎ 
a Division of Plastic and Reconstructive Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
b Division of Surgical Oncology, Department of Surgery, Kaohsiung Medical University Hospital, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
c Department of Pathology, Kaohsiung Medical University Hospital, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
d Cancer Center, Kaohsiung Medical University Hospital, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
e Department of Pathology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
f Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan
Correspondence to: Maw-Chang Sheen, MD, Division of Surgical Oncology, Department of Surgery, Kaohsiung Medical University Hospital, 100 Tz You 1st Road, Kaohsiung, Taiwan| Supported by a grant from the Department of Health, Executive Yuan Republic of China (Taiwan) (DOH101-TD-C-111-002). |
|
| Conflicts of interest: None declared. |
© 2012
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 67 - N° 6
P. e263-e264 - décembre 2012 Retour au numéro
Article précédent
- Escitalopram oxalate (Lexapro)-induced acneiform eruption
- Sarika Khanna, Rodolfo E. Chirinos, Suraj Venna
- Acute myeloid leukemia presenting with cutaneous infiltrates in a patient receiving etanercept for chronic lymphocytic vasculitis
- Muriel Sadlier, Gerard Connaghan, Brian Kirby
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?